Showing results (211-220 of 785) with videos related to
Sort By:
Pageof 79
International Journal of Oncology|May 12, 2011
Multidrug-resistance gene (mdr1) expression in human tumor xenograftsY Abe, M Nakamura, Y Ohnishi, et al.Journal of Immunology (Baltimore, Md. : 1950)|February 24, 2001
Differential regulation of human blood dendritic cell subsets by IFNsT Ito, R Amakawa, M Inaba, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|October 1, 1985
[Antitumor activities of orally administered 4-carbamoylimidazolium-5-olate (SM-108)]M Nakamura, M Fukui, S Morisada, et al.Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|September 1, 1995
Multiple elements in the 5' untranslated region down-regulate c-sis messenger RNA translationP Horvath, A Suganuma, M Inaba, et al.Immunobiology|November 1, 1990
Auto-MHC class II-reactive T cell line obtained from MRL/+mice suffering from "lpr-GVHD". I. Characterization of surface phenotypes, specificities and functions in vitroN Nagata, R Yasumizu, Y Ohnishi, et al.Hypertension Research : Official Journal of the Japanese Society of Hypertension|February 7, 1998
Glucose intolerance in spontaneously hypertensive and Wistar-Kyoto rats: enhanced gene expression and synthesis of skeletal muscle glucose transporter 4S Katayama, M Inaba, Y Maruno, et al.Journal of Immunology (Baltimore, Md. : 1950)|July 22, 1999
Primed T cells are more resistant to Fas-mediated activation-induced cell death than naive T cellsM Inaba, K Kurasawa, M Mamura, et al.Hypertension Research : Official Journal of the Japanese Society of Hypertension|December 29, 2000
Blood pressure control in Japanese hypertensives with or without type 2 diabetes mellitusS Katayama, M Inaba, T Morita, et al.[Zasshi] [Journal]. Nihon Kyobu Geka Gakkai|July 1, 1995
[Emergency CABG and mitral valve replacement for anterolateral papillary muscle rupture after acute myocardial infarction]K Goh, Y Kubo, T Sasajima, et al.The British Journal of Dermatology|April 1, 1992
Primary cutaneous plasmacytoma: treatment with intralesional tumour necrosis factor-alphaR Tsuboi, R Morioka, H Yaguchi, et al.Pageof 79